Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $84.3600 (2.5%) ($83.5900 - $84.7100) on Tue. Feb. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.16% (three month average) | RSI | 35 | Latest Price | $84.3600(2.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(53%) DIA(52%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.58% in a week (0% probabilities). VIXM(-36%) VXX(-14%) TLT(-14%) IGOV(-5%) UUP(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.58% (StdDev 1.16%) | Hourly BBV | 1.4 () | Intraday Trend | 0.9% | | | |
|
1 - 5 Day Possible Target | $77.02(-8.7%) | Resistance Level | $86.1 | 5 Day Moving Average | $82.53(2.22%) | 10 Day Moving Average | $83.57(0.95%) | 20 Day Moving Average | $86.1(-2.02%) | To recent high | -6.5% | To recent low | 4.1% | Market Cap | $148.835b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |